期刊文献+

载脂蛋白AV水平及-1131T>C基因多态性与脑梗死 被引量:1

Serum apoiipoprotein AV level and-1131 T>C gene polymorphism in patients with cerebral infarction
下载PDF
导出
摘要 目的研究血清载脂蛋白AV(apolipoprotein AV,apoAV)水平及其与甘油三酯的关系在脑梗死患者和正常人群之间的差异,并观察脑梗死急性期血清apoAV水平的动态变化。探讨apoAV基因-1131 T>C多态性与血清apoAV水平、甘油三酯水平及脑梗死之间的关系。方法采用病例对照研究,在湖南汉族人群中筛选123例急性期脑梗死患者及113例年龄和性别匹配的健康体检人群为研究对象。应用双抗体夹心ELISA方法测定研究对象血清apoAV水平。采用聚合酶链反应一限制性片段长度多态性(PCR-RFLP)法检测apoAV-1131 T>C基因型。结果研究总人群中血清apoAV水平与甘油三酯水平呈负相关(rs=-0.132,P<0.05)。病例组中血清apoAV水平与脑梗死NIHSS评分间有呈正相关的趋势,但无统计学意义(rs=0.161,P>0.05)。ApoAV-1131 T>C各基因型间血清apoAV水平无显著性差异(均P>0.05)。多因素logistic回归分析显示apoAV-1131 C等位基因是脑梗死的独立危险因素(OR=1.897,95%CI 1.029~3.499,P<0.05)。结论在湖南汉族非脑梗死人群中,血清apoAV具有降低甘油三酯水平的作用,其水平在急性脑梗死患者与正常人群之间无明显差异。ApoAV-1131 C等位基因是脑梗死的独立危险因素,其与甘油三酯水平升高有关,但与apoAV水平无关。 Objective To explore the difference in the level of serum apolipoprotein AV (apoAV) between cerebral infarction patients and normal population and the relationship between the levels of serum apoAV and triglyceride. To inves- tigate the gene frequencies of apoAV-1131T 〉 C gene polymorphism, and the association between apoAV-1131 T 〉 C gene polymorphisrri with the levels of serum apoAV,triglyceride or cerebral infarction. Methods A case-control study on 123 patients with cerebral infarction and 113 healthy controls was carried out. The level of serum apoAV was determined by double antibody sandwich ELISA. The genotype and allele frequencies of apoAV-1131 T 〉 C gene polymorphism were as- sayed by polymerase chain reaction-restricted fragments length polymorphism (PCR-RFLP). Results Serum apoAV con- centration was negatively correlated with triglyceride( r = - 0. 132, P 〈 0.05 ). The trend of positive correlation was found between the level of serum apoAV and NIHSS seore,but no statistically significance( rs =0. 161 ,P 〉 0.05). There was no significant difference of serum apoAV level among apoAV-1131 T 〉 C genotypes. ApoAV-1131 C allele was independently associated with an increased risk of cerebral infarction( OR = 1. 897,95% CI 1. 029 - 3. 499,P 〈 0.05 ). Conclusion Ser- um apoAV reduced the level of triglyceride in the normal population, but did not in the acute stage of cerebral infarction. ApoAV-1131 C allele is an independent risk factor for cerebral infarction, but theit increased serum triglyceride level was not through changing the level of serum apoAV.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2013年第2期108-114,共7页 Journal of Apoplexy and Nervous Diseases
关键词 载脂蛋白AV 脑梗死 甘油三酯 多态性 Apolipoprotein AV Cerebral infarction Triglyceride Polymorphism
  • 相关文献

参考文献35

  • 1Pennacchio LA, Olivier M, Hubacek JA, et al, An apolipoprotein influ- encing triglycerides in humans and mice revealed by comparativese- quencing[ J ]. Science,2001,294 (5540) : 169 - 173.
  • 2van der Vliet HN, Sammels MG, Leegwater AC, et al. Apolipoprotein A-V:a novel apolipoprotein associated with an early phase of liverre- generation[ J]. J Biol Chem ,2001,276 (48) :44512 - 44520.
  • 3van der Vliet HN, Sehaap FG, Levels JH,et al. Adenoviral overexpres- sion of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice [ J ]. Biochem B70phys Res Common, 2002,295 (5) :1156 -1159.
  • 4Grosskopf I, Baroukh N, Lee S J, et al. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipoly- sis of triglyeeride-rich lipoproteins and removal of their remnants[ Jl. Arterioscler Thromb Vase Bio1,2005,25 ( 12 ) :2573 - 2579.
  • 5Mattei J, Demissie S, Tucker KL, et al. Apolipoprotein A5 polymor- phisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults [ J ] : J Nutr,2009, 139 (12) :2301 -2308.
  • 6Maasz A, Kisfali P, Horvatovieh K, et al. Apolipoprotein A5 T-1131 C variant confers risk for metabolic syndrome [ J ]. Pathol Oneol Res, 2007,13 (3) :243 -247.
  • 7Khovidhunkit W, Duehateau PN, Medzihradszky KF, et al. Apolipopro- teins A-IV and A-V are acute-phase proteins in mouse HDL[ J]. Ath- erosclerosis ,2004,176( 1 ) :37 -44.
  • 8Hordestgaard BG, Zacho J. Lipids, atheroselerosis and CVD risk:is CRP an innocent bystander[ J]. Nutr Metab Cardiovasc Dis,2009,19 (8) :521 -524.
  • 9Libby P, Okamoto Y, Roeha VZ, et al. Inflammation in atherosclerosis : transition from theory to practice[ J]. Cire J,2010,74(2) :213 -220.
  • 10Orr AW, Hastings NE, Blackman BR, et al. Complex regulation andfunction of the inflammatory smooth muscle cell phenotype in athero- sclerosis [ J ]. J Vasc Res, 2010,47 ( 2 ) : 168 - 180.

二级参考文献13

  • 1Tanne D, Koren-Morag 5I, Graft E, et al. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the bezafibrate infarction prevention (hip) registry: high triglycerides constitute an independent risk factor. Circulation, 2001, 104:2892-2897.
  • 2Pikija S, Milevcic D, Trkulja V, et al. Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans. Eur Neurol , 2006, 55:89-92.
  • 3Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density hpoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study. BMJ, 1994, 309:11-15.
  • 4Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science, 2001, 294:169-173.
  • 5van der Vilet HN, Sammels MG, Leegwater AC, et al. apolipoproteinA V : a novel apolipoprotein associated with a nearly phase of liver regeneration. J Biol Chem, 2001, 276:44512-44520.
  • 6Pennacehio LA, Olivier M, Hubacek JA, et al. Two independent apolipeprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet , 2002, 11:3031-3038.
  • 7Hubacek J, Skodova Z, Adamkova V, et al. The influence of APOA5 polymorphisms (T- 1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet, 2004, 65:126-130.
  • 8Liu H, Zhang S, Lin J, et al. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism, 2005, 54: 568-572.
  • 9Yamada Y, Kato K, Hibino T, et al. Prediction of genetic risk for metabolic syndrome. Atherosclerosis, 2007, 191:298-304.
  • 10Hsu LA, Ko YL, Chang CJ, et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis, 2006, 185:143-149.

共引文献33023

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部